Tofacitinib for the Treatment of Polyarticular Course Juvenile Idiopathic Arthritis: Results of a Phase 3 Randomized, Double-blind, Placebo-controlled Withdrawal Study. 2019 ACR/ARP Annual Meeting; October 23, - Brunner, H; Synoverska, O; Ting, T (2019)
Atlanta 2019